Product Name: Myo Reagent Kit (Quantitative)
Method: Laternal-Flow technology (Fluorescent Immunochromatographic)
Product Models: 5 tests/box, 25 tests/box, 40 tests/box, 100 tests/box
CFDA Registration No.: 20152400177
Certification: CE, SGS ISO13485, ISO9001
Matching Equipments: Solid Phase Fluorescence Immunoassay System (KOFA Brand).
Introduction: This reagent kit is base on fluorescent chromatographic technology, supporting the quantitative rapid test of Myo level in the serum/plasma, and Myo is the sensitive indicator for the early acute myocardial infraction (AMI)
Myo Technical Parameters:
Test Item | Sample | Reading Time | Testing Time |
Myo | Plasma/Serum:50μL Whole Blood:100μL | 15min | 3S |
The advantages of Myo
1. Advanced fluoroimmunoassay quantitative testing platform, make accurate and quantitative rapid test of Myo level available
2. Low cost and rapid test, can get the quantitative and reliable results in 15minutes, shorten the testing turnaround time.
3. The testing results of this Myo kit have good correlation with that of Roche diagnostics (compared with thousands of cases)
4. Simple operation and rapid test, can meet the need of various departments.
5. The combined detection of Myo, cTnI and CK-MB contributes to the early diagnosis of acute myocardial infraction, AMI.
Applicable Departments: Departments of cardiology, surgery, geriatrics respiratory emergency ward and ICU.
Contact: Donald Qian
Phone: +86 172 4949 3008
Tel: +86 172 4949 3008
Company: Fortune BioSciences
Add: Gaoxin Avenue, East Lake New Technology Development Zone, 430075 Wuhan, Hubei, P.R. China.